pH-sensitive polymeric micelles for targeted delivery to inflamed joints
Chunhong Li1, Hanmei Li1, Qin Wang1
1Key Laboratory of Drug Targeting and Drug Delivery Systems, Ministry of Education, West China School of Pharmacy, Sichuan University, Chengdu, Sichuan, PR China.
New pH-sensitive polymeric micelles effectively deliver prednisolone (PD) to inflamed joints in rheumatoid arthritis models. This targeted approach enhances drug concentration in joints, improving anti-inflammatory effects compared to free PD.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Rheumatology
Background:
- Rheumatoid arthritis treatment is limited by drugs that cannot selectively target inflamed joints.
- Conventional drug delivery systems like liposomes and micelles can be unstable, leading to uncontrolled drug release.
Purpose of the Study:
- To develop a novel pH-sensitive polymeric micelle system for targeted delivery of prednisolone (PD) to inflamed joints.
- To evaluate the stability, drug release kinetics, and therapeutic efficacy of PD-loaded micelles in a rheumatoid arthritis mouse model.
Main Methods:
- Synthesized amphiphilic conjugates of a PEG-based derivative and prednisolone (PD).
- Formed pH-sensitive polymeric micelles via self-assembly, characterized by drug loading.
- Administered PD micelles intravenously to mice with collagen-induced arthritis and assessed drug distribution, plasma/joint concentrations, and pharmacodynamics.
Main Results:
- PD micelles achieved a drug loading of 19.29% and demonstrated pH-sensitive drug release in acidic environments.
- Intravenous injection of PD micelles resulted in significant accumulation of PD in the joints of arthritic mice.
- PD concentrations in plasma and joints were significantly higher with PD micelles compared to free PD, with 4.63-fold and 2.50-fold increases in AUC and Cmax in joints, respectively.
Conclusions:
- PD micelles show promise as a targeted drug delivery system for inflammatory diseases like rheumatoid arthritis.
- The pH-sensitive micelle system enhances joint drug accumulation and improves anti-inflammatory and disease-modifying effects.
More Related Videos
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Modified-Release Drug Delivery Systems: Stimuli-Activated
Modified-Release Drug Delivery Systems: Site-Targeted
Inflammation
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF


